What is the recommended dose of acyclovir (antiviral medication) for varicella (chickenpox) prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Prophylaxis Dosing for Varicella

For varicella prophylaxis after exposure, the recommended dose is acyclovir 20 mg/kg (maximum 800 mg) orally four times daily for 5-7 days, initiated 7-10 days after exposure when varicella-zoster immune globulin (VZIG) is unavailable or if more than 96 hours have passed since exposure. 1

Primary Prophylaxis Strategy

VZIG remains the first-line prophylaxis for susceptible high-risk individuals (immunocompromised, pregnant women, neonates) after varicella exposure, administered within 96 hours of exposure at 125 units/10 kg body weight (maximum 625 units) intramuscularly. 1

Acyclovir as Alternative Prophylaxis

When VZIG is unavailable or the 96-hour window has passed, acyclovir prophylaxis becomes the recommended alternative:

  • Dosing regimen: 20 mg/kg body weight (maximum 800 mg per dose) orally four times daily for 5-7 days 1
  • Timing: Initiate 7-10 days after exposure, corresponding to the late incubation period when secondary viremia begins 1
  • Target population: Susceptible immunocompromised patients and other high-risk individuals without evidence of immunity 1

Evidence Supporting This Approach

The 7-10 day post-exposure timing is critical because it targets the late incubation period:

  • Research demonstrates that oral acyclovir administered 9 days after exposure prevented clinical varicella in 92.6% of exposed children, with seroconversion occurring in 63% 2
  • Another study showed that starting acyclovir 7-9 days post-exposure reduced disease incidence from 100% to 16% in family contacts 3
  • This late-incubation timing allows for natural immune response development while preventing clinical disease 3, 2

Special Populations

Immunocompromised Children

  • Same dosing: 20 mg/kg (maximum 800 mg) four times daily 1
  • Close physician observation is mandatory, as some patients may require conversion to intravenous therapy 4

Pregnant Women

  • VZIG is strongly preferred within 96 hours of exposure 1, 5
  • If VZIG unavailable: oral acyclovir 10 mg/kg four times daily for 7 days can be considered 1
  • Acyclovir is FDA Category B with no increased birth defects in 596 first-trimester exposures 5

HIV-Infected Patients

  • For prophylaxis after exposure: 20 mg/kg (maximum 800 mg) four times daily for 5-7 days 1
  • Note: Data on acyclovir preventing chickenpox in HIV-infected individuals are limited 1

Important Clinical Caveats

Common pitfall: Starting acyclovir too early (immediately after exposure) may interfere with natural immunity development. The 7-10 day delay is intentional and evidence-based. 3, 2

Monitoring requirement: Patients on prophylaxis should be observed closely, as breakthrough disease can still occur and may require escalation to intravenous therapy. 4

Duration of protection: Unlike VZIG which provides approximately 3 weeks of protection, acyclovir prophylaxis only covers the treatment period. 1

Renal Dose Adjustment

For patients with renal impairment receiving the 800 mg four times daily regimen:

  • Creatinine clearance >25 mL/min: 800 mg every 4 hours (5 times daily)
  • Creatinine clearance 10-25 mL/min: 800 mg every 8 hours
  • Creatinine clearance 0-10 mL/min: 800 mg every 12 hours
  • Hemodialysis: Additional dose after each dialysis session 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral acyclovir prophylaxis of varicella after intimate contact.

The Pediatric infectious disease journal, 1997

Guideline

Acyclovir Dosing for Varicella in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.